Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluciclovine PET-CT for Response in Metastatic Prostate Cancer
NCT04134208Phase 4Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluciclovine f 18 in prostate carcinoma, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2019; status: terminated.
02
Drugs
fluciclovine f 18
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT04134208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134208.